AC Immune ACIU
NASDAQ ACIU
$2.41 -0.09 (-3.40%)
As of: Oct 23, 2026 · 1:24 PM EDT

AC Immune (ACIU) Short-term Investments (2014 - 2026)

Updated

AC Immune's Short-term Investments was $60.23 million in the quarter ended Jun 30, 2026, down 50.8% from $122.5 million a year earlier and down 15.2% from the prior quarter.

Analysis

AC Immune (ACIU) Short-term Investments (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, Short-term Investments at AC Immune came in at $77.94 million, down 46.9% from the prior year.

  • Short-term Investments shows a five-year compound annual growth rate of 2.4% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Short-term Investments was $146.88 million in the year ended Dec 31, 2024 (+98.5%), $73.98 million in the year ended Dec 31, 2023 (-22.4%), $95.39 million in the year ended Dec 31, 2022 (-24.9%) and $126.94 million in the year ended Dec 31, 2021 (+83.2%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Short-term Investments since the quarter ended Mar 31, 2024.
  • Compared with a year earlier, Short-term Investments has declined for five straight quarters, with growth averaging 29.1% over the last eight quarters.
  • The best year-over-year quarter for Short-term Investments over five years was the quarter ended Dec 31, 2023 (growth of 188.7%); the worst was the quarter ended Mar 31, 2023 (a decline of 58.7%).
  • Per Business Quant data, ACIU's Short-term Investments in the three quarters before the quarter ended Jun 30, 2026 was $71.04 million (quarter ended Mar 31, 2026), $80.85 million (quarter ended Dec 31, 2025) and $100.92 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn
10 AC Immune 243.32 Mn -195.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.94 Mn
Mar 31, 2026 69.55 Mn
Dec 31, 2025 81.62 Mn
Sep 30, 2025 101.26 Mn
Jun 30, 2025 127.04 Mn
Mar 31, 2025 142.65 Mn
Dec 31, 2024 143.06 Mn
Sep 30, 2024 149.29 Mn
Jun 30, 2024 137.52 Mn
Mar 31, 2024 53.06 Mn
Dec 31, 2023 29.11 Mn
Sep 30, 2023 52.47 Mn
Jun 30, 2023 58.95 Mn
Mar 31, 2023 52.55 Mn
Dec 31, 2022 98.61 Mn
Sep 30, 2022 98.47 Mn
Jun 30, 2022 95.37 Mn
Mar 31, 2022 125.68 Mn
Dec 31, 2021 126.96 Mn
Sep 30, 2021 101.69 Mn
API Access

AC Immune Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ACIU&period=max&api_key=YOUR_API_KEY